Skip to main content
VCbacked
Log inGet Started

Aurealis Therapeutics

Kuopio, Finland

Aurealis Therapeutics is a swiss-finnish private biopharmaceutical company that specializes in cell and gene therapies for chronic wounds.

$9.0M raised
Nov 2024
Venture - Series Unknown
BiotechnologyPharmaceuticalTherapeutics

Top Investors

TesiLynx CapitalZhejiang Huahai Pharmaceutical

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aurealis Therapeutics

How much funding has Aurealis Therapeutics raised?
Aurealis Therapeutics has raised $9.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2024.
Who are Aurealis Therapeutics's investors?
Aurealis Therapeutics's investors include Tesi, Lynx Capital, Zhejiang Huahai Pharmaceutical.
Where is Aurealis Therapeutics headquartered?
Aurealis Therapeutics is headquartered in Kuopio, Finland.
What does Aurealis Therapeutics do?
Aurealis Therapeutics is a swiss-finnish private biopharmaceutical company that specializes in cell and gene therapies for chronic wounds.
What stage is Aurealis Therapeutics at?
Aurealis Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aurealis Therapeutics — Funding & Investors." VCBacked, November 13, 2024, https://www.vcbacked.co/company/aurealis-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). Aurealis Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/aurealis-therapeutics
Wikipedia (cite web)
{{cite web |title=Aurealis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aurealis-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K